Laboratory features and the successful transplantation of allogeneic peripheral blood stem cells in patients with lymphoma-associated hemophagocytic lymphohistiocytosis.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease that is commonly caused by lymphoma. The authors describe laboratory features and the successful treatment of two patients with lymphoma- associated HLH. Hematologic investigations, bone marrow aspirates and biopsies, and PET/CT scans were performed. Both patients received a transplantation of allogenic peripheral blood stem cells after chemotherapy. The patients achieved complete remission and have survived for three or more years after treatment with chemotherapy and an allogenic peripheral blood stem cell transplantation. Allogeneic peripheral blood stem cell transplantation may be the most effective therapy for patients with lymphoma-associated hemophagocytic lymphohistiocytosis.